SEC Form SC 13G filed by InMed Pharmaceuticals Inc.

InMed Pharmaceuticals, Inc.

(Name of Issuer)

Common Shares, no par value

(Title of Class of Securities)

457637601

(CUSIP Number)

September 30, 2024

(Date of Event Which Requires Filing of the Statement)

☒

Rule 13d-1(b)

☐

Rule 13d-1(c)

☐

Rule 13d-1(d)

Cusip No. 457637601

Page 2 of 5 Pages

1.	NAME OF REPORTING PERSONS   AdvisorShares Trust
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a)  ☐     (b)  ☐
3.	SEC USE ONLY
4.	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5.	SOLE VOTING POWER	733,296
		6.	SHARED VOTING POWER	0
		7.	SOLE DISPOSITIVE POWER	733,296
		8.	SHARED DISPOSITIVE POWER	0
9.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON			733,296
10.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES			☐
11.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)			8.77%
12.	TYPE OF REPORTING PERSON (See Instructions)			IV

Item 1(a).

Name of Issuer:  InMed Pharmaceuticals, Inc.

Item 1(b).

Address of Issuer’s Principal Executive Offices:

Item 2(a).

Name of Person Filing: AdvisorShares Trust

Item 2(b).

Address of Principal Business Office or, if none, Residence:

Item 2(c).

Citizenship: Delaware

Item 2(d).

Title of Class of Securities:  Common Shares, no par value

Item 2(e).

CUSIP Number: 457637601

Item 3.

If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

	(a)	[  ]	Broker or dealer registered under Section 15 of the Act (15 U.S.C 78o);
	(b)	[  ]	Bank as defined in Section 3(a)(6) of the Act (15 U.S.C 78c);
	(c)	[  ]	Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C 78c);
	(d)	[X]	Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
	(e)	[ ]	An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
	(f)	[  ]	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
	(g)	[  ]	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
	(h)	[  ]	A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
	(i)	[  ]	A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);
	(j)	[  ]	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);
	(k)	[   ]	Group, in accordance with § 240.13d-1(b)(1)(ii)(K).

Item 4.

Ownership:

(a)

Amount beneficially owned:  733,296

(b)

Percent of Class: 8.77%

(c)

Number of shares as to which such person has:

(i)

sole power to vote or to direct the vote: 733,296

(ii)

shared power to vote or to direct the vote: 0

(iii)

sole power to dispose or to direct the disposition of: 733,296

(iv)

shared power to dispose or to direct the disposition of: 0

Item 5.

Ownership of Five Percent or Less of a Class:

Item 6.

Ownership of More than Five Percent on Behalf of Another Person:

Item 7.

Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:

Item 8.

Identification and Classification of Members of the Group:

Item 9.

Notice of Dissolution of Group:

	November 12, 2024
	(Date)
	/s/ Stefanie Little
	(Signature)
	Stefanie Little – Chief Compliance Officer
	Name and Title